Literature DB >> 2341093

Inhibition of protein synthesis in rat primary hepatocytes by extracts of Fusarium moniliforme-contaminated corn.

W P Norred1, C W Bacon, J K Porter, K A Voss.   

Abstract

Mycological screening of two separate lots of corn samples that caused field cases of equine leukoencephalomalacia (ELEM) revealed heavy contamination with the fungus Fusarium moniliforme. Neutral and acidic fractions of a chloroform-methanol (1:1, v/v) extract of the corn were evaluated for toxicity using rat primary hepatocytes. The extracts had little effect on the release of lactate dehydrogenase from the hepatocytes, and were without effect on unscheduled DNA synthesis, indicating low cell lethality and lack of genotoxicity. However, neutral extracts of the corn were found to contain potent inhibitor(s) of protein synthesis as measured by incorporation of [3H]valine into the hepatocytes. When an isolate of F. moniliforme obtained from the corn samples or an isolate of F. moniliforme from South Africa that had previously been shown to cause ELEM (MRC 826) were grown on autoclaved seed corn, neutral extracts of the culture materials similarly inhibited protein synthesis. Whether the compound(s) responsible for inhibition of protein synthesis is associated with any of the toxic syndromes associated with F. moniliforme remains to be determined. The use of primary hepatocytes may be a useful bioassay for elucidating biologically active secondary metabolites of fungi.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341093     DOI: 10.1016/0278-6915(90)90015-f

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  10 in total

1.  Differential cytotoxicity and mycotoxin content among isolates of Fusarium moniliforme.

Authors:  W P Norred; C W Bacon; R D Plattner; R F Vesonder
Journal:  Mycopathologia       Date:  1991-07       Impact factor: 2.574

2.  Development of an L6 myoblast in vitro model of moniliformin toxicosis.

Authors:  R Reams; H L Thacker; M Novilla; D Laska; J Horn; D Harrington; W Greenlee; R Vesonder
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

3.  Purified moniliformin does not affect the force or rate of contraction of isolated guinea pig atria.

Authors:  R Y Reams; H L Thacker; D D Harrington; M N Novilla; B Wilson
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

4.  Comparative pathologic changes in broiler chicks on feed amended with Fusarium proliferatum culture material or purified fumonisin B1 and moniliformin.

Authors:  T Javed; R M Bunte; M A Dombrink-Kurtzman; J L Richard; G A Bennett; L M Côté; W B Buck
Journal:  Mycopathologia       Date:  2005-06       Impact factor: 2.574

5.  Embryopathic and embryocidal effects of purified fumonisin B1 or Fusarium proliferatum culture material extract on chicken embryos.

Authors:  T Javed; J L Richard; G A Bennett; M A Dombrink-Kurtzman; R M Bunte; K W Koelkebeck; L M Côté; R W Leeper; W B Buck
Journal:  Mycopathologia       Date:  1993-09       Impact factor: 2.574

6.  Subchronic toxicological investigations of Fusarium moniliforme-contaminated corn, culture material, and ammoniated culture material.

Authors:  K A Voss; W P Norred; C W Bacon
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

7.  The mycotoxin fumonisin B1 inhibits eukaryotic protein synthesis: in vitro and in vivo studies.

Authors:  R Karuna; R B Sashidhar
Journal:  Mycopathologia       Date:  2007-10-30       Impact factor: 2.574

8.  Enterobacter cloacae is an endophytic symbiont of corn.

Authors:  D M Hinton; C W Bacon
Journal:  Mycopathologia       Date:  1995       Impact factor: 2.574

9.  Discovery and occurrence of the fumonisins: a historical perspective.

Authors:  W F Marasas
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

10.  Statistically designed experiments to screen chemical mixtures for possible interactions.

Authors:  J P Groten; O Tajima; V J Feron; E D Schoen
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.